Cost-Effectiveness of Combination Disease-Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial. (2020)

First Author: Patel A
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/acr.23830

PubMed Identifier: 30629813

Publication URI: http://europepmc.org/abstract/MED/30629813

Type: Journal Article/Review

Volume: 72

Parent Publication: Arthritis care & research

Issue: 3

ISSN: 2151-464X